Merck reports strong Q1 results
It appears Merck's current line-up of drugs has filled the void left by the loss of Zocor last year. The company announced strong Q1 results, with worldwide sales at $5.8 billion for the quarter--an increase of 7 percent from the first quarter of 2006. Overall, Merck's first-quarter profit jumped 12 percent, due to strong sales and money earned from product divestitures. Release